Regulus, UCSD to Collaborate on miRNA Treatments for Angiogenic Disease

The research will combine Regulus' miRNA platform with UCSD's expertise in animal models of angiogenesis, the company said.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories